Lactones: Generic Inhibitors of Enzymes?

Author(s): Monika I. Konaklieva, Balbina J. Plotkin

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 5 , Issue 1 , 2005

Become EABM
Become Reviewer


The ability to affect eukaryotic and prokaryotic cellular growth, signaling and differentiation is a continuing focus in the pharmaceutical industry. The fundamental ability to affect these cellular processes is inherent in lactones. Lactones, which are ubiquitous in nature, reflect a broad phylogenetic diversity indicative of their ability to act as simple alkylating compounds, with their in situ activities falling into one of two categories, i.e., protect or conquer. Medically, their utility as pharmaceutical agents range from that of antimicrobial to anti-neoplastic agent depending on the functional groups attached.

Keywords: lactones, dna polymerases, human immunodeficiency virus type 1 (hiv-1) reverse transcriptase, cytokines

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [73 - 95]
Pages: 23
DOI: 10.2174/1389557053402828

Article Metrics

PDF: 23